Biomedical Catalyst 2021 Round 2: Feasibility & Primer Awards

Biomedical Catalyst 2021 Round 2: Feasibility & Primer Awards
Founders: -
Funding type: Grant
Total fund: Up to £12 million
Award: £50,000 and £1million
Publication date: 11 October 2021
Period: Monday 18 October 2021 - 1 December 2021 11:00am

UK registered businesses can apply for a share of up to £12 million to develop innovative healthcare products, technologies and processes.



  • Competition opens: Monday 18 October 2021

  • Competition closes: Wednesday 1 December 2021 11:00am 


Your project can focus on:



  • disease prevention and proactive management of health and chronic conditions

  • earlier and better detection and diagnosis of disease, leading to better patient outcomes

  • tailored treatments that either change the underlying disease or offer potential cures


This competition combines the feasibility and primer strands of the Biomedical Catalyst.


The feasibility award is designed for projects that have developed an innovative concept or carried out experimental proof of concept but have not validated the technology. The aim of the feasibility award is to explore and evaluate the commercial potential of innovative ideas.


Your project’s total eligible costs must be between £50,000 and £1million.


Your project must:



  • have total eligible costs between £50,000 and £1million

  • start on 1 April 2022

  • end by 31 March 2024

  • last between 3 months and 24 months

  • carry out all of its project work in the UK

  • intend to exploit the results from or in the UK


To lead a project or work alone your organisation must be a UK registered micro, small or medium-sized enterprise (SME)


Academic institutions cannot lead or work alone.


To collaborate with the lead, your organisation must be one of the following UK registered:



Each partner organisation must be invited into the Innovation Funding Service by the lead to collaborate on a project. Once accepted, partners will be asked to login or to create an account and enter their own project costs into the Innovation Funding Service.


In a collaboration, the lead and at least one other organisation must claim funding by entering their costs during the application.


Large companies can be collaborators but will not be able to claim grant funding.


Your project can include partners that do not receive any of this competition’s funding, for example non-UK businesses. Their costs will count towards the total eligible project costs.


Not award you funding if you have:



For feasibility studies and industrial research projects, you could get funding for your eligible project costs of:



  • up to 70% if you are a micro or small organisation

  • up to 60% if you are a medium-sized organisation


Research participation


The research organisations undertaking non-economic activity as part of the project can share up to 50% of the total eligible project costs. If your consortium contains more than one research organisation undertaking non-economic activity, this maximum is shared between them.



Of that 50% you could get funding for your eligible project costs of up to:



  • 80% of full economic costs (FEC) if you are a Je-s registered institution such as an academic

  • 100% of your eligible project costs if you are an RTO, charity, non-profit organisation, public sector organisation or research organisation


Your project can:



  • review research evidence and identify possible applications

  • assess business opportunities

  • assess or protect intellectual property

  • validate initial concepts and existing pre-clinical work through experimental studies

  • initially demonstrate using in-vitro and in-vivo models, but not human clinical trials

  • develop early-stage prototyping

  • acquire preliminary regulatory advice

Free consultation